Erythromycin pills

Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban

Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…

View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Procedure

Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients

Dr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.

View More Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients